Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Main Line Health CCOP

Award Number: U10CA063847
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/05/1994
PERIOD OF PERFORMANCE END DATE: 07/31/2014

Group Awards By:

View Award Description

Main Line Health CCOP - DESCRIPTION (provided by applicant): In this renewal application for the CCOP grant, we propose to maintain the Main Line Heath CCOP as a consortium of cancer clinical trials programs amongst Lankenau Medical Center, Bryn Mawr Hospital and Paoli Hospital, Our broad and long term objective is to provide access to state-of-the-art cancer clinical trials as a service line, reduce barriers to accruals, and educate the community, inclusive of our healthcare colleagues, about cancer clinical trials (myths & facts). This will ultimately improve patient awareness, services, and clinical outcomes to the nearly 1 million people residing in the Main Line Health system's community service area. This service area includes Western Philadelphia, Montgomery, Chester, and Delaware Counties of Pennsylvania. To accomplish our objectives, the Main Line Health CCOP is affiliated with the following Research Bases: Eastern Cooperative Oncology Group (ECOG), Gynecologic Oncology Group (GOG), National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), MD Anderson Cancer Center, and Wake Forest Comprehensive Cancer Center. 85% of cancer patients are diagnosed and treated in their local communities. The NCCN Clinical Practice Guidelines state that the best management of any cancer patient is in a clinical trial. Main Line Health CCOP serves as an accrual group by providing access to national NCI-approved cancer prevention, control, and treatment clinical trials to patients and physicians in their own community, right where they live. By providing access to cancer clinical trials and a network to expedite the knowledge gained from national clinical trials to our community multi-disciplinary cancer programs, quality cancer care is fostered. Main Line Health has designated Research and Education among the system's top five strategic initiatives. In addition, Main Line Health has launched a new brand strategy that encourages our community to stay "Well Ahead" by embracing a healthier lifestyle and taking advantage of our preventive care, disease management, and educational programs.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2015 ( Subtotal = $0 )
2015	2013	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	20	10/15/2014	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2014 ( Subtotal = $82,373 )
2014	2014	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	20	5/29/2014	SUPPLEMENT FOR EXPANSION	$82,373
														Subtotal = $82,373

Issue Date FY: 2013 ( Subtotal = $414,235 )
2013	2013	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	20	6/26/2013	NON-COMPETING CONTINUATION	$414,235
														Subtotal = $414,235

Issue Date FY: 2012 ( Subtotal = $509,235 )
2012	2012	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Treatment Research	000	19	7/16/2012	COMPETING CONTINUATION	$509,235
														Subtotal = $509,235

Issue Date FY: 2011 ( Subtotal = $541,320 )
2011	2011	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	001	18	8/26/2011	NON-COMPETING CONTINUATION	$250,660
2011	2011	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	002	18	9/15/2011	NON-COMPETING CONTINUATION	$80,000
2011	2011	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	18	6/30/2011	NON-COMPETING CONTINUATION	$210,660
														Subtotal = $541,320

Issue Date FY: 2010 ( Subtotal = $350,000 )
2010	2010	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	17	5/27/2010	NON-COMPETING CONTINUATION	$350,000
														Subtotal = $350,000

Issue Date FY: 2009 ( Subtotal = $410,000 )
2009	2009	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	16	5/21/2009	NON-COMPETING CONTINUATION	$410,000
														Subtotal = $410,000

Issue Date FY: 2008 ( Subtotal = $477,455 )
2008	2008	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	15	7/21/2008	NON-COMPETING CONTINUATION	$477,455
														Subtotal = $477,455

Issue Date FY: 2007 ( Subtotal = $480,000 )
2007	2007	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	14	8/28/2007	COMPETING CONTINUATION	$480,000
														Subtotal = $480,000

Issue Date FY: 2006 ( Subtotal = $380,000 )
2006	2006	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	13	6/28/2006	NON-COMPETING CONTINUATION	$380,000
														Subtotal = $380,000

Issue Date FY: 2004 ( Subtotal = $461,522 )
2004	2004	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	11	6/30/2004	NON-COMPETING CONTINUATION	$461,522
														Subtotal = $461,522

Issue Date FY: 2003 ( Subtotal = $374,190 )
2003	2003	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	10	7/7/2003	NON-COMPETING CONTINUATION	$374,190
														Subtotal = $374,190

Issue Date FY: 2002 ( Subtotal = $531,351 )
2002	2002	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	9	9/13/2002	COMPETING CONTINUATION	$531,351
														Subtotal = $531,351

Issue Date FY: 2001 ( Subtotal = $406,195 )
2001	2001	LANKENAU MEDICAL RESEARCH CENTER	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	8	9/11/2001	NON-COMPETING CONTINUATION	$406,195
														Subtotal = $406,195

Issue Date FY: 2000 ( Subtotal = $310,369 )
2000	2000	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	7	7/25/2000	NON-COMPETING CONTINUATION	$310,369
														Subtotal = $310,369

Issue Date FY: 1999 ( Subtotal = $269,121 )
1999	1999	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	6	6/10/1999	NON-COMPETING CONTINUATION	$269,121
														Subtotal = $269,121

Issue Date FY: 1998 ( Subtotal = $220,802 )
1998	1998	LANKENAU INSTITUTE FOR MEDICAL RESEARCH	100 LANCASTER AVENUE	WYNNEWOOD	PA	19096	MONTGOMERY	USA	Cancer Control	000	5	6/26/1998	NON-COMPETING CONTINUATION	$220,802
														Subtotal = $220,802

Grand Total All Awards = $6,218,168

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Main Line Health CCOP

Award Number: U10CA063847

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/05/1994

PERIOD OF PERFORMANCE END DATE: 07/31/2014

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer